Current status for the treatment of extranodal nasal type NK/T cell lymphoma / 国际肿瘤学杂志
Journal of International Oncology
; (12): 554-556, 2015.
Article
in Zh
| WPRIM
| ID: wpr-467527
Responsible library:
WPRO
ABSTRACT
The most of extranodal nasal type NK/ T-cell lymphoma(ENKTL)are in the Ⅰ/ Ⅱ stage. Radiotherapy alone is insufficient to achieve a high cure rate for the early stage patients with ENKTL due to fre-quent local and systemic relapse. Concomitant/ sequential chemotherapy and radiotherapy is the standard treat-ment for the early stage patients with ENKTL. For the patients with stage Ⅲ/ Ⅳ ENKTL,regimens containing L-asparaginase are most effective. For the patients with advanced stage ENKTL or refractory recurrent ENKTL, hematopoietic stem cell transplantation may be considered when the remission is achieved.
Full text:
1
Index:
WPRIM
Language:
Zh
Journal:
Journal of International Oncology
Year:
2015
Type:
Article